Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022
| Autor: | Freedman, R.A., Heiling, H.M., Li, T., Trapani, D., Tayob, N., Smith, K.L., Davis, R., Pereslete, A.M., DeMeo, M.K., Cotter, C., Chen, W.Y., Parsons, H.A., Santa-Maria, C.A., Van Poznak, C., Moy, B., Brufsky, A.M., Melisko, M.E., O’Sullivan, C.C., Ashai, N., Rauf, Y., Nangia, J.R., Burns, R.T., Savoie, J., Wolff, A.C., Winer, E.P., Rimawi, M.F., Krop, I.E., Lin, N.U. |
|---|---|
| Zdroj: | In Annals of Oncology November 2024 35(11):993-1002 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|